The fact that benfotiamine-induced vacuolization requires both new protein synthesis and a functional BK channel in the target cells suggest that the anti-leukemia activity of benfotiamine may be mediated through paraptosis, which is an alternative cell death mechanism recently described [20]. The gene discussed is KCNMA1; the disease is leukemia.